Cleared Special

K130112 - CAPNO MODULE, 92517

K130112 is an FDA 510(k) clearance for CAPNO MODULE, manufactured by Spacelabs Healthcare. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Special 510(k) pathway after a 64-day FDA review.

K130112 · Spacelabs Healthcare · Anesthesiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Mar 2013
Decision
64d
Days
Class 2
Risk

K130112 is an FDA 510(k) clearance for the CAPNO MODULE, 92517. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Spacelabs Healthcare (Nederland, US). The FDA issued a Cleared decision on March 21, 2013 after a review of 64 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K130112

510(k) Number K130112 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 16, 2013
Decision Date March 21, 2013
Days to Decision 64 days
Submission Type Special
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
76d faster than avg
Panel avg: 140d · This submission: 64d
Pathway characteristics
Modification to existing cleared device.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 266
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K130112.
M1 CAPNOGRAPHY MASK
K133806 · Monitor Mask, Inc. · Dec 2013
CAPNOMASK
K131339 · Mediplus , Ltd. · Nov 2013
TG-970P SENSOR KIT W/ NEW AIRWAY ADAPTER (YG-213T)
K122214 · Nihon Kohden Corp. · May 2013
DISPOSABLE GAS SAMPLING LINE WITH AND WITHOUT IN-LINE FILTER
K122075 · Intersurgical, Inc. · Dec 2012
MICROSTREAM FILTERLINE ICU
K121927 · Oridion Medical 1987 , Ltd. · Nov 2012
IRMA C02 MODEL 200101
K123043 · Phasein AB · Oct 2012